JSR Will Buy Swiss Selexis to Expand Biopharma Business Jun. 19, 2017 JSR Corp. (TYO:4185) has announced plans to acquire Selexis SA, a company with specialized cell line generation technology. The Swiss…... Please subscribe to read the full story. Subscribe Free Trial